Saltwater solution could break deadly Heart-Kidney cycle
NCT ID NCT07596329
First seen Jun 27, 2026 · Last updated Jul 16, 2026 · Updated 2 times
Summary
This study tests whether adding a small amount of saltwater (hypertonic saline) to a standard water pill (furosemide) can help people with heart failure and kidney disease. The goal is to improve fluid removal, reduce hospital readmissions, and lower the risk of death. The trial will enroll 60 adults with chronic heart and kidney problems, and compare the combination therapy against standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could delaying kidney implant during heart transplant reduce complications?
- A simple conversation could change how heart failure patients care for themselves
- A picture-based lesson may help heart failure patients spot trouble early
- Can a Two-Drug punch early in hospitalization tame heart failure?
- Bedside flu shot for heart patients: a simple strategy to save lives?
- AI takes on sonographers: a 4,000-Patient trial to sharpen heart imaging